Similar articles

• T helper 17 cells get the NOD.

  Stetson DB, Medzhitov R. Stetson DB, et al. Immunity. 2007 Oct;27(4):546-8. doi: 10.1016/j.immuni.2007.10.005. Immunity. 2007. PMID: 17967409 Review.
• The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.

  Rogler G. Rogler G. Gut. 2010 Feb;59(2):153-4. doi: 10.1136/gut.2009.193185. Gut. 2010. PMID: 20176638 No abstract available.
• Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease.

  Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH. Gewirtz AT, et al. Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1157-63. doi: 10.1152/ajpgi.00544.2005. Epub 2006 Jan 26. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16439468 Clinical Trial.
• Immunopathogenesis of inflammatory bowel disease: current concepts.

  Bamias G, Cominelli F. Bamias G, et al. Curr Opin Gastroenterol. 2007 Jul;23(4):365-9. doi: 10.1097/MOG.0b013e3281c55eb2. Curr Opin Gastroenterol. 2007. PMID: 17545770 Review.
• Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.

  Strober W, Asano N, Fuss I, Kitani A, Watanabe T. Strober W, et al. Immunol Rev. 2014 Jul;260(1):249-60. doi: 10.1111/imr.12193. Immunol Rev. 2014. PMID: 24942694 Review.